🟢 AIM ImmunoTech is trading 5% up today in pre-market with no clearly identified company-specific catalyst

AIM ImmunoTech is trading +5.01% at $0.22, with no clearly identified company-specific catalyst for the September 22, 2026, pre-market move.

• Recent company press releases concern Ampligen patents and pancreatic-cancer development, dated September 2 and September 9, rather than September 22.
• Broader markets are mixed, offering limited confirmation of a market-wide driver.